GlassScriptPhysician profile
Sarah Rubin
NPI 1396350740
$1,341.27
in general payments reported to CMS, 2019-2025
15 companies · $21.56 in 2025
The $21.56 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $137 · 2023: $544 · 2024: $639 · 2025: $21.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190 · Education: $14.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.83 |
| Education | $14.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $447.70 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $227.35 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $161.30 | 2023-2024 | Tepezza, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.07 | 2023-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $88.01 | 2023-2024 | |
| Xeris Pharmaceuticals, INC. | $72.46 | 2023-2024 | Gvoke Hypopen |
| Alexion Pharmaceuticals, INC. | $62.20 | 2024 | Strensiq |
| Radius Health, INC. | $38.32 | 2023-2024 | Tymlos |
| Sanofi-Aventis U.S. LLC | $31.57 | 2023 | |
| Beta Bionics, INC. | $26.17 | 2024 | Ilet Bionic Pancreas |
| Mannkind Corporation | $25.58 | 2023 | Afrezza |
| Cequr Corporation | $23.31 | 2023 | Cequr Simplicity |
| Tandem Diabetes Care, INC. | $16.51 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Siemens Medical Solutions USA, INC. | $14.80 | 2024 | Dca Systems Hemoglobin A1c Reagent Kit |
| Organon LLC | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.